Search Count: 120
All
Selected
 |
Organism: Phaeobacter porticola
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2026-04-29 Classification: TRANSFERASE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION, SOLUTION SCATTERING Resolution:1.63 Å Release Date: 2026-04-22 Classification: IMMUNE SYSTEM |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2026-04-22 Classification: IMMUNE SYSTEM |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.94 Å Release Date: 2026-04-22 Classification: IMMUNE SYSTEM |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.38 Å Release Date: 2026-04-01 Classification: OXIDOREDUCTASE |
 |
Whole Structure Of C44S/C47S Double Mutant Form Of Human Prostamide/Prostaglandin F Synthase (Pgfs)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2026-04-01 Classification: OXIDOREDUCTASE |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2025-12-03 Classification: IMMUNE SYSTEM |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBOTOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Organism: Gallus gallus
Method: ELECTRON MICROSCOPY Release Date: 2025-08-06 Classification: PROTEIN FIBRIL |
 |
Organism: Gallus gallus
Method: ELECTRON MICROSCOPY Release Date: 2025-08-06 Classification: PROTEIN FIBRIL |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-04-30 Classification: MEMBRANE PROTEIN |
 |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-04-30 Classification: MEMBRANE PROTEIN |
 |
Organism: Montipora sp. 20
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-04-23 Classification: FLUORESCENT PROTEIN |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2024-09-11 Classification: IMMUNE SYSTEM |
 |
Cryo-Em Structure Of The Hiv-1 Jr-Fl Idl Env Trimer In Complex With Pgt122 Fab
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-07-31 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG, SO4 |
 |
Cryo-Em Structure Of The Hiv-1 Bg505 Idl Env Trimer In Complex With 3Bnc117 And 10-1074 Fabs
Organism: Human immunodeficiency virus 1, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-07-31 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |